995 resultados para Moscardo, Lodovico, conte.


Relevância:

20.00% 20.00%

Publicador:

Resumo:

Mode of access: Internet.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

University of Illinois Library bookplate "From the library of Conte Antonio Cavagna Sangiuliani di Gualdana Lazelada di Bereguardo, purchased 1921" on the inside front cover.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

"Contemporaneità."

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Mode of access: Internet.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

A reprint of the edition of 1875-1882.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

First presented on Sept. 9, 1834 at the Accademia della Crusca.

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Holograph, signed.

Relevância:

20.00% 20.00%

Publicador:

Relevância:

20.00% 20.00%

Publicador:

Resumo:

Le sujet de cette recherche concerne l'évaluation de l'influence d'une approche pédagogique adaptée tenant compte des dimensions affective et cognitive de la clientèle d'une classe de maturation. Cette approche dite "adaptée" utilise le livre, le conte et les habiletés du conteur dans le but de développer une propension à la lecture chez ces élèves. À la lumière des ouvrages des auteurs tels que Jackson, Hayden, Bettelheim, Jean, Held, Michel et Seung sur l'influence affective et cognitive du livre, du conte et des habiletés du conteur chez l'individu ainsi qu'à la lumière du modèle théorique de la compréhension du rôle de l'affectivité relié au processus de la lecture de Mathewson, nous avons formulé l'hypothèse que l'application de l'approche pédagogique adaptée axée sur le conte et les habiletés du conteur augmente la propension à la lecture chez les élèves d'une classe de maturation. La cueillette des données a été réalisée à l'aide de l'évaluation d'un expert (avant et après l'application de l'approche pédagogique adaptée), d'un questionnaire adressé aux sujets, d'un questionnaire adressé aux parents (avant et après l'application de l'approche pédagogique adaptée) et des observations de l'enseignante. L'analyse de l'ensemble des résultats et des observations durant la période de l'expérimentation confirment l'hypothèse de cette recherche.

Relevância:

10.00% 10.00%

Publicador:

Resumo:

Purpose: This randomized, multicenter trial compared first-line trastuzumab plus docetaxel versus docetaxel alone in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC). Patients and Methods: Patients were randomly assigned to six cycles of docetaxel 100 mg/m 2 every 3 weeks, with or without trastuzumab 4 mg/kg loading dose followed by 2 mg/kg weekly until disease progression. Results: A total of 186 patients received at least one dose of the study drug. Trastuzumab plus docetaxel was significantly superior to docetaxel alone in terms of overall response rate (61% v 34%; P = .0002), overall survival (median, 31.2 v 22.7 months; P = .0325), time to disease progression (median, 11.7 v 6.1 months; P = .0001), time to treatment failure (median, 9.8 v 5.3 months; P = .0001), and duration of response (median, 11.7 v 5.7 months; P = .009). There was little difference in the number and severity of adverse events between the arms. Grade 3 to 4 neutropenia was seen more commonly with the combination (32%) than with docetaxel alone (22%), and there was a slightly higher incidence of febrile neutropenia in the combination arm (23% v 17%). One patient in the combination arm experienced symptomatic heart failure (1%). Another patient experienced symptomatic heart failure 5 months after discontinuation of trastuzumab because of disease progression, while being treated with an investigational anthracycline for 4 months. Conclusion: Trastuzumab combined with docetaxel is superior to docetaxel alone as first-line treatment of patients with HER2-positive MBC in terms of overall survival, response rate, response duration, time to progression, and time to treatment failure, with little additional toxicity. © 2005 by American Society of Clinical Oncology.